| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 12, 2004
Accepted on March 30, 2005
Molecular Endocrinology Laboratory, VA Greater Los Angeles Healthcare System, Departments of Medicine and Physiology, David Geffen School of Medicine at UCLA, Los Angeles, California 90073 (T.K., Y.K., A.I.L., L.H.C., E.O., K.T., G.A.B), Vitae Pharmaceuticals, Irvine, California (R.A.C.); Third Department of Medicine, Yamanashi University, Yamanashi 409-3898, Japan (K.T., T.S.)
* To whom correspondence should be addressed. E-mail: gbrent{at}ucla.edu.
The sodium/iodide symporter (NIS) mediates iodide uptake in lactating breast tissue and is expressed in some breast cancers. We have previously demonstrated that all-trans retinoic acid (tRA) stimulates NIS gene expression and the selective cytotoxic effect of 
-emitting 131I in both in vitro and in vivo MCF-7 breast cancer cell systems. We studied the ability of natural and synthetic retinoids, in combination with other nuclear receptor ligands, to achieve greater and more sustained induction of NIS in MCF-7 cells and enhance 131I-mediated cytotoxicity. Selective stimulation of retinoic acid receptor (RAR) /
produced marked NIS induction and selective stimulation of RAR
, RAR, or retinoid X receptor (RXR), produced more modest induction. Maximal NIS induction was seen with 9-cis RA and AGN190168, a RAR / agonist. Dexamethasone (Dex), but not the other nuclear receptor ligands, in combination with tRA synergistically induced iodide uptake and NIS mRNA expression, predominantly by prolonging NIS mRNA half-life. The addition of Dex reduced the EC50 of tRA for NIS stimulation to 
7%, such that 10-7 M tRA with addition of Dex enhanced iodide uptake and selective cytotoxicity of 131I greater than 10-6 M tRA alone. AGN190168 combined with Dex synergistically increased iodide uptake and significantly prolonged induction (5 days) of iodide uptake compared with that induced by the combination of tRA/Dex or 9-cis RA/Dex. The addition of Dex reduced the effective dose of retinoid, and prolonged the induction of NIS, especially with AGN190168, suggesting higher efficacy of 131I after combination treatment.
This article has been cited by other articles:
 |
|
 |
|
  T. Kogai, E. Ohashi, M. S. Jacobs, S. Sajid-Crockett, M. L. Fisher, Y. Kanamoto, and G. A. Brent Retinoic Acid Stimulation of the Sodium/Iodide Symporter in MCF-7 Breast Cancer Cells Is Meditated by the Insulin Growth Factor-I/Phosphatidylinositol 3-Kinase and p38 Mitogen-Activated Protein Kinase Signaling Pathways J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1884 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Fenton, K. M. Marion, and J. M. Hershman Identification of Cyclic Adenosine 3',5'-Monophosphate Response Element Modulator as an Activator of the Human Sodium/Iodide Symporter Upstream Enhancer Endocrinology, May 1, 2008; 149(5): 2592 - 2606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Lim, J. C. Paeng, S. J. Kim, S. Y. Kim, H. Lee, and D. H. Moon Enhanced Expression of Adenovirus-Mediated Sodium Iodide Symporter Gene in MCF-7 Breast Cancer Cells with Retinoic Acid Treatment J. Nucl. Med., March 1, 2007; 48(3): 398 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Riesco-Eizaguirre and P. Santisteban A perspective view of sodium iodide symporter research and its clinical implications. Eur. J. Endocrinol., October 1, 2006; 155(4): 495 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Kogai, K Taki, and G A Brent Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 797 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Dohan, A. De la Vieja, and N. Carrasco Hydrocortisone and Purinergic Signaling Stimulate Sodium/Iodide Symporter (NIS)-Mediated Iodide Transport in Breast Cancer Cells Mol. Endocrinol., May 1, 2006; 20(5): 1121 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yu, J. Han, J. Lin, Y. Xiao, X. Zhang, and Y. Li Apoptosis Induced by atRA in MEPM Cells Is Mediated through Activation of Caspase and RAR Toxicol. Sci., February 1, 2006; 89(2): 504 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Unterholzner, M. J. Willhauck, N. Cengic, M. Schutz, B. Goke, J. C. Morris, and C. Spitzweg Dexamethasone Stimulation of Retinoic Acid-Induced Sodium Iodide Symporter Expression and Cytotoxicity of 131-I in Breast Cancer Cells J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 69 - 78. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
